Skip to main content
. 2022 Jan 5;16:418–432. doi: 10.1016/j.bioactmat.2021.12.029

Scheme 1.

Scheme 1

Schematic illustration of remodeling the tumor immunosuppressive microenvironment by the all-in-one CS-I/J@CM NPs to improve the immunotherapy of glioblastoma.